FSD Pharma Submits a Phase-1 Multiple Ascending Doses Clinical Trial Application for Lucid-21-302 (Lucid-MS) for Ethics Committee Review in Australia

2 years ago

TORONTO, ON / ACCESSWIRE / May 7, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical…

Avinger to Announce First Quarter 2024 Results on May 15, 2024

2 years ago

REDWOOD CITY, CA / ACCESSWIRE / May 7, 2024 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the…

Ainos Raises $9 Million in Growth Capital with Existing Shareholder

2 years ago

Proceeds for scaling up the company's VELDONA and AI Nose growth initiativesConvertible note convertible at $4.5 per share placed with…

CMTA Appoints Science and Technology Veteran, Patricia Verduin, PhD, to the Board of Directors

2 years ago

Patricia Verduin, PhD, brings extensive science, technology, and sustainability expertise as well as business acumen to CMTA Board of DirectorsPatricia's…

Ipsen S.A. – Formalities for making available and consulting preparatory documents to the 2024 Annual General Meeting

2 years ago

    Information relating to the holding of the Combined Shareholders’ Meeting of 28 May 2024 of Ipsen S.A. Formalities…

Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa

2 years ago

Cannabix is developing alcohol and marijuana breathalyzer devices to give law enforcement and employers a tool to enhance public safetyVANCOUVER,…

Inozyme Pharma Reports First Quarter 2024 Financial Results and Provides Business Highlights

2 years ago

- Interim data from SEAPORT-1, a Phase 1 trial of INZ-701 in patients with end-stage kidney disease receiving hemodialysis, on…

Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024

2 years ago

Company to host conference call to discuss financial results and provide a corporate update on May 13, 2024 at 4:30…

Scorpius Holdings Appoints New VP of Business Development Shari Udoff-McDonald

2 years ago

Biopharma industry veteran joins Scorpius’ leadership teamDURHAM, N.C., May 07, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc. (NYSE American: SCPX)…

Palisade Bio Appoints Margery Fischbein to its Board of Directors

2 years ago

Palisade Bio, Inc. Margery Fischbein Wall Street and biotech industry veteran with expertise across corporate finance, business development, M&A, licensing,…